Continuity of Capital
By investing in projects from inception through to pre-IPO, we intend to facilitate the continuity of capital from Australian academia to venture financing and through Australian capital markets.
Our investments are divided according to stage of development, where we intend to deploy:
up to A$1M into early stage projects (discovery through lead optimisation)
A$3-5M into medium stage projects (establishing preclinical proof of concept)
up to A$5M into late preclinical/ early clinical programs.